With the dedication and hard work of our Colombian team, PharmaCielo achieves another important milestone.
The State-of-the-Art Processing and Extraction Centre of PharmaCielo is now GMP certified for Phytotherapeutics. Read more: https://t.co/OOlXn195Qg
Our CEO, Henning von Koss, spoke to @MuggleheadMag about Colombia’s new cannabis regulations and how the new legal framework will support the growth of the local industry and the business potential for PharmaCielo, both home and abroad.
Read here: https://t.co/fn1UypETxr
Our CEO, Henning von Koss, spoke with CannaList EU about the importance of producing consistent and unified APIs at scale for end-product manufacturers in the pharma and wellness/functional foods sectors.
Watch the interview here: https://t.co/zkQJ0CKubX
Our CEO, Henning von Koss, spoke with @bofc_canada about the role PharmaCielo plays in the Cannabis supply chain and how it enables B2B clients to develop new and innovative end-user products.
Watch the interview here: https://t.co/1zvM9bcPNj
https://t.co/SHhXRP5Hl7
PharmaCielo makes initial shipment of CBD Isolate to a Canadian life sciences company that specializes in developing and commercializing proprietary drug delivery technologies.
Read more here: https://t.co/ubcXmhx1qK
“We are here for the marathon, setting standards for other cannabis companies.”
Our CEO, Henning von Koss talks about PharmaCielo’s continuous emphasis on quality and the importance of being an early mover in the cannabis industry.
Read the article here: https://t.co/PFx2llHjHo
Watch our CEO, Henning von Koss on @SeekingAlpha talk about PharmaCielo’s unique business strategy and market position.
He also discusses his journey and bringing pharma standards to cannabis.
Watch the interview here: https://t.co/UfjdfK3F46
“PharmaCielo Mexico is well positioned to be an early mover on the Mexican medical cannabis market and is expected to become a primary supplier of premium medical extracts.” - @Technical420 Read more here: https://t.co/8u5VsHHAEV #cannabisindustry#cannabis#cannabiz
We’re preparing for the #GMP audit process at our new processing center (PEC), as well as expecting the Colombian and Mexican GMP certifications in Q1’21 and Q2’21. Also, PEC will be operating in #compliance with EU-GMP guidelines by the end of February. https://t.co/jPHqiaMwPR
With legislation approved in #Mexico to establish a framework for #medicalcannabis use, PharmaCielo CEO noted the country is set up for rapid expansion since “the learning curve is smaller." More here: https://t.co/PPZkQnlAfh #cannabis#legalization
The United Nations Commission on Narcotic Drugs made a historic decision to remove #cannabis from the global narcotics drugs list. The vote recognizes the World Health Organization’s recommendation to acknowledge the therapeutic properties of cannabis. https://t.co/hTqjSxKH43
PharmaCielo and its European joint venture, PharmaCielo Italia, commend the Court of Justice of the E.U. for its landmark ruling to exempt #CBD as a narcotic substance. A positive step in the right direction. #cannabis#legalization https://t.co/LgGxtM3ruz
Congratulations to Mexico on the recent advancement towards the #legalization of adult-use #cannabis, which includes provision for import of medicinal extracts and products! This is an important milestone that will benefit so many and the Mexican economy at large.
PharmaCielo continues to grow its global footprint with commercial shipments of medicinal grade CBD isolate to a distributor and manufacturer based in the U.K. with sales and distribution network on the Island and broader E.U. Read more here https://t.co/jTDeQbvhdo. #cannabis
Tune in on November 20 from 1:20 to 2:00 PM (ET) to hear from PharmaCielo’s Chief Corporate Officer David Gordon as he participates in a Market Forum panel as part of #MJBizCon. Learn more here https://t.co/ALRlOTBkUc #cannabisindustry#cannabis#cannabiz